HbA1C and serum fructosamine in diabetic patients: relationship to age, clotting and fibrinolysis parameters and urinary microalbumin excretion.
Van Wersch
J W
JW
Haematology Laboratory, De Wever Hospital, Heerlen, The Netherlands.
Westerhuis
L W
LW
Venekamp
W J
WJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood*; D000419:Albuminuria / Q000652:urine; D000990:Antithrombin III / Q000032:analysis; D001777:Blood Coagulation / Q000502:physiology*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005260:Female; D005342:Fibrinolysis / Q000502:physiology*; D019270:Fructosamine; D006442:Glycated Hemoglobin / Q000032:analysis*; D006595:Hexosamines / Q000097:blood*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010447:Peptide Hydrolases / Q000032:analysis; D015849:Plasminogen Inactivators / Q000032:analysis
D000990:Antithrombin III; D019270:Fructosamine; D006442:Glycated Hemoglobin; D006595:Hexosamines; D010447:Peptide Hydrolases; D015849:Plasminogen Inactivators; C046193:antithrombin III-protease complex